It is likely that Cigna would cover Wegovy for this use with a prior authorization, but its best to check with your specific plan to be sure
2017: The FDA approves Novo Nordisks Ozempic (semaglutide, a glucagon-like peptide-1 receptor agonist) to treat type 2 diabetes in eligible patients
The common adverse reactions of GLP-1R agonists include gastrointestinal reactions, mainly loss of appetite, nausea, vomiting, diarrhea, abdominal pain, etc., primarily mild or moderate
TRT has been associated with lower levels of total cholesterol and LDL
After menopause, women face specific health challenges, such as bone health, heart health, and maintaining overall vitality